Axa Parenterals Limited, a active public limited company, was established on 22 July 2005 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2005PLC148247. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹7.38 Cr.
It upholds a compliant status. Employing 295 professional, Its leadership includes Sunil Kumar Agarwal (Director), Vikas Khanna (Director), Yasha Agarwal (Whole-Time Director). Past directors included Shashi Bhushan Garg, Milap Kapoor, Yasha Agarwal. It holds ₹212.35 Cr open charges and ₹459.83 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 703-704, Pearls Best Height-2, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
U24232DL2005PLC148247
148247
22 July 2005
₹7.50 Cr
₹7.38 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Axa Parenterals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Kumar Agarwal | Director | 22 Feb 2019 | Current |
| Vikas Khanna | Director | 16 Aug 2019 | Current |
| Yasha Agarwal | Whole-Time Director | 01 Jan 2023 | Current |
| Ruchir Gupta | Whole-Time Director | 01 Oct 2010 | Current |
| Sumit Kumar Agarwal | Whole-Time Director | 01 Oct 2010 | Current |
| Vijaysing Krupalsing Bhandari | Director | 16 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | 04 May 2020 | Past |
| Pramod Abcsdd | Director | 16 Apr 2018 | Past |
| Pramod Abcsdd | Additional Director | 24 Feb 2023 | Past |
| Pramod Abcsdd | Director | 01 Apr 2011 | Past |
| Pramod Abcsdd | Director | 01 Nov 2008 | Past |
| Pramod Abcsdd | Director | 09 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Axa Parenterals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 12.36% increase. The company also saw a slight decrease in profitability, with a 0.65% decrease in profit. The company's net worth Soared by an impressive increase of 77.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Axa Parenterals had a promoter holding of 17.82% and a public holding of 82.18%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,123,510,000.00
₹4,598,339,017.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2025 | Others | ₹1.50 M | Open |
| 18 Oct 2024 | Hdfc Bank Limited | ₹3.00 M | Open |
| 13 Oct 2023 | Others | ₹147.00 Cr | Open |
| 18 Aug 2023 | Hdfc Bank Limited | ₹2.01 M | Open |
| 01 Jan 2022 | Others | ₹64.25 Cr | Open |
Explore comprehensive loan charge details -
Axa Parenterals has a workforce of 295 employees as of Dec 18, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Axa Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axa Parenterals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 04 Mar 2021 via Charge ID 100422826 with Others was fully satisfied on 18 Sep 2025. was documented.
Progress on A charge registered on 06 Jan 2020 via Charge ID 100318018 with Others was fully satisfied on 18 Sep 2025. was documented.
Progress on A charge registered on 30 Dec 2019 via Charge ID 100317711 with Others was fully satisfied on 18 Sep 2025. was documented.
The activity A charge with Others amounted to Rs. 0.15 Cr with Charge ID 101146882 was registered on 30 Jul 2025. was completed.
A charge with Others of Rs. 64.25 Cr registered on 01 Jan 2022 with Charge ID 100539293 was modified on 18 Dec 2024. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100995657 was registered on 18 Oct 2024. was completed.
The CIN of Axa Parenterals Limited is U24232DL2005PLC148247.
Axa Parenterals Limited is headquartered at 703-704, Pearls Best Height-2, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
Axa Parenterals Limited was incorporated on 22 July 2005.
The current directors of Axa Parenterals Limited are
The primary industry of Axa Parenterals Limited is Manufacturing.
Axa Parenterals Limited is unlisted.
The authorized capital of Axa Parenterals Limited is ₹7.50 Cr, and the paid-up capital is ₹7.38 Cr.
The compliance status of Axa Parenterals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX